PTEN loss induces epithelial - Mesenchymal transition in human colon cancer cells

Anticancer Research

Volumn 29, Issue 11, 2009, Pages 4439-4449

  Bowen, Kanika A ^a   Doan, Hung Q ^a   Zhou, Binhua P ^a,b   Wang, Qingding ^a   Zhou, Yuning ^a   Rychahou, Piotr G ^a   Evers, B Mark ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

EMT; Invasion; Migration; PTEN; TNF

Indexed keywords

BETA CATENIN; CYCLIN D1; MYC PROTEIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL INTERFERING RNA; TENSIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOACCUMULATION; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CHROMOSOME 10; COLON CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MESENCHYME; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; COLONIC NEOPLASMS; EPITHELIAL CELLS; GENE KNOCKOUT TECHNIQUES; HCT116 CELLS; HUMANS; MESODERM; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; RATS; RNA, SMALL INTERFERING; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 75149135196     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Baker CV: The evolution and elaboration of vertebrate neural crest cells. Curr Opin Genet Dev 18: 536-543, 2008.
2. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC and Lothe RA: The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45: 31-41, 2006.
3. Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749, 2005.
4. Jeanes A, Gottardi CJ and Yap AS: Cadherins and cancer: how does Cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929, 2008.
5. Suzuki H, Masuda N, Shimura T, Araki K, Kobayashi T, Tsutsumi S, Asao T and Kuwano H: Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res 28: 1821-1830, 2008.
6. Locksley RM, Killeen N and Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501, 2001.
7. Tsianos EV and Katsanos K: Do we really understand what the immunological disturbances in inflammatory bowel disease mean? World J Gastroenterol 15: 521-525, 2009.
8. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
9. Rychahou PG, Jackson LN, Silva SR, Rajaraman S and Evers BM: Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma. Ann Surg 243: 833-842; discussion 843-834, 2006.
10. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G and Testa JR: Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer 64: 280-285, 1995.
11. Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK and Testa JR: Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc Natl Acad Sci USA 93: 3636-3641, 1996.
12. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M and Mak TW: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8: 1169-1178, 1998.
13. Di Cristofano A, Pesce B, Cordon-Cardo C and Pandolfi PP: PTEN is essential for embryonic development and tumour suppression. Nat Genet 19: 348-355, 1998.
14. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE and Parsons R: Mutation of PTEN/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96: 1563-1568, 1999.
15. Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, Xiao SY, Chung DH and Evers BM: Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci USA 105: 20315-20320, 2008.
16. Nassif NT, Lobo GP, Wu X, Henderson CJ, Morrison CD, Eng C, Jalaludin B and Segelov E: PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene 23: 617-628, 2004.
17. Abubaker J, Bavi P, Al-Harbi S, Ibrahim M, Siraj AK, Al-Sanea N, Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S and Al-Kuraya KS: Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene 27: 3539-3545, 2008.
18. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN and Evers BM: Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem 279: 4285-4291, 2004.
19. Kumar S and Weaver VM: Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 28: 113-127, 2009.
20. Mbeunkui F and Johann DJ Jr: Cancer and the tumor micro-environment: a review of an essential relationship. Cancer Chemother Pharmacol 63: 571-582, 2009.
21. Jackson LN, Li J, Chen LA, Townsend CM and Evers BM: Overexpression of wild-type PKD2 leads to increased proliferation and invasion of BON endocrine cells. Biochem Biophys Res Commun 348: 945-949, 2006.
22. Etienne-Manneville S: Polarity proteins in migration and invasion. Oncogene 27: 6970-6980, 2008.
23. Rajput A, Dominguez San Martin I, Rose R, Beko A, Levea C, Sharratt E, Mazurchuk R, Hoffman RM, Brattain MG and Wang J: Characterization of HCT116 human colon cancer cells in an orthotopic model. J Surg Res 147: 276-281, 2008.
24. Granger GA, Shacks SJ, Williams TW and Kolb WP: Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature 221: 1155-1157, 1969.
25. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N and Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666-3670, 1975.
26. Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33, 2009.
27. Gavert N and Ben-Ze'ev A: beta-Catenin signaling in biological control and cancer. J Cell Biochem 102: 820-828, 2007.
28. Huang D and Du X: Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J Gastroenterol 14: 1823-1827, 2008.
29. Brabletz S, Schmalhofer O and Brabletz T: Gastrointestinal stem cells in development and cancer. J Pathol 217: 307-317, 2009.
30. Thiery JP: Epithelial mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
31. Dejana E, Orsenigo F and Lampugnani MG: The role of adherens junctions and VE Cadherin in the control of vascular permeability. J Cell Sci 121: 2115-2122, 2008.
32. Guarino M, Rubino B and Ballabio G: The role of epithelial mesenchymal transition in cancer pathology. Pathology 39: 305-318, 2007.
33. Fan D, Morgan LR, Schneider C, Blank H and Fan S: Cooperative evaluation of human tumor chemosensitivity in the soft-agar assay and its clinical correlations. J Cancer Res Clin Oncol 109: 23-28, 1985.
34. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE and Hall DM: Molecular interactions in cancer cell metastasis. Acta Histochem 2009.
35. Brugge J, Hung MC and Mills GB: A new mutational AKTivation in the PI3K pathway. Cancer Cell 12: 104-107, 2007.
36. Keniry M and Parsons R: The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27: 5477-5485, 2008.
37. Wang H, Quah SY, Dong JM, Manser E, Tang JP and Zeng Q: PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 67: 2922-2926, 2007.
38. Simpson L and Parsons R: PTEN: life as a tumor suppressor. Exp Cell Res 264: 29-41, 2001.
39. Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M and Takeyama H: Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 8: 56, 2008.
40. Parsons DW, Wang TL, Samuels Y, Bardelli A, Cummins JM, DeLong L, Silliman N, Ptak J, Szabo S, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Lengauer C and Velculescu VE: Colorectal cancer: mutations in a signalling pathway. Nature 436: 792, 2005.
41. Hu TH, Wang CC, Huang CC, Chen CL, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS and Tai MH: Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection. Oncol Rep 18: 1417-1426, 2007.
42. Maehama T and Dixon JE: PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol 9: 125-128, 1999.
43. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and Larue L: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003.
44. Kattla JJ, Carew RM, Heljic M, Godson C and Brazil DP: Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial mesenchymal transition in vitro and in vivo. Am J Physiol Renal Physiol 295: F215-225, 2008.
45. Wallerand H, Cai Y, Wainberg ZA, Garraway I, Lascombe I, Nicolle G, Thiery JP, Bittard H, Radvanyi F and Reiter RR: Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Urol Oncol (Epub ahead of print).
46. Shao J, Evers BM and Sheng H: Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells. Cancer Res 64: 229-235, 2004.
47. Leslie NR, Yang X, Downes CP and Weijer CJ: PtdIns(3,4,5) P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 17: 115-125, 2007.
48. Karin M and Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759, 2005.
49. Karin M: Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006.
50. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM and Zhou BP: Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 75:416-428, 2009.
51. Li B, Vincent A, Cates J, Brantley-Sieders DM, Polk DB and Young PP: Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res 69: 338-348, 2009.
52. Csiszar A, Szentes T, Haraszti B, Zou W, Emilie D, Petranyi G and Pocsik E: Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas. Eur Cytokine Netw 12: 87-96, 2001.
53. Chuang MJ, Sun KH, Tang SJ, Deng MW, Wu YH, Sung JS, Cha TL and Sun GH: Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial mesenchymal transition in renal cell carcinoma cells. Cancer Sci 99: 905-913, 2008.
54. Brabletz T, Jung A, Dag S, Reu S and Kirchner T: β-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma. Verh Dtsch Ges Pathol 84: 175-181, 2000.
55. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM and Oshima M: Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J 27: 1671-1681, 2008.
56. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci USA 98: 10356-10361, 2001.